Pediatrics

Episodes 1-5 of 5

• • 

    

    Philip Stein, MD

    Peer

  • 

    

    Neilanjan Nandi, MD

    Peer

  • 

    

    Susan Peck, MSN, CRNP

    Peer

  12

  

  RestartResume

  The Crohn’s & Colitis Foundation's Camp Oasis: A Clinician's Perspective

  RestartResume

  The Crohn’s & Colitis Foundation's Camp Oasis: A Clinician's Perspective

  The Crohn’s & Colitis Foundation's Camp Oasis: A Clinician's Perspective

• • 

    

    John J. Russell, MD

    Peer

  • 

    

    Thomas Doyle, MD

    Peer

  9

  

  RestartResume

  Heart of the Matter: Emerging Treatment Options for Congenital Heart Disease

  RestartResume

  Heart of the Matter: Emerging Treatment Options for Congenital Heart Disease

  Heart of the Matter: Emerging Treatment Options for Congenital Heart Disease
• 18

  

  RestartResume

  Anti-TNFα Treatment After Surgical Resection for Crohn's Disease Is Effective Despite Previous Pharmacodynamic Failure

  RestartResume

  Anti-TNFα Treatment After Surgical Resection for Crohn's Disease Is Effective Despite Previous Pharmacodynamic Failure

  Anti-TNFα Treatment After Surgical Resection for Crohn's Disease Is Effective D…

• • 

    

    Adam Ehrlich, MD, MPH

    Peer

  • 

    

    Philip Stein, MD

    Peer

  10

  

  RestartResume

  Growing Up With IBD: When to Transition to an Adult GI Specialist

  RestartResume

  Growing Up With IBD: When to Transition to an Adult GI Specialist

  Growing Up With IBD: When to Transition to an Adult GI Specialist
• 12

  

  RestartResume

  Vedolizumab as Induction and Maintenance Therapy for Crohn’s Disease in Patients Naïve to or Who Have Failed Tumor Necrosis Factor Antagonist Therapy

  RestartResume

  Vedolizumab as Induction and Maintenance Therapy for Crohn’s Disease in Patients Naïve to or Who Have Failed Tumor Necrosis Factor Antagonist Therapy

  Vedolizumab as Induction and Maintenance Therapy for Crohn’s Disease in Patient…